This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
THE SPRINGTIME PARTNERING EVENT
March 23–25, 2026 | Lisbon, PortugalMarch 25–26, 2025 | Digital Partnering

Tom Shepherd
CEO at Captor Therapeutics
Speaker

Profile

Chief Executive Officer (President of the Management Board) at Captor Therapeutics S.A., a Polish Biopharmaceutical company listed on the Warsaw stock exchange focused on the discovery, development and commercialisation of innovative drugs in the rapidly growing field of targeted protein degradation. Tom has over thirty years’ experience of leadership positions in pharma and biotechnology companies in the UK, USA, France, Switzerland, Australia and Poland, securing 13 major license agreements, 6 private / VC investor rounds and 3 IPOs. Awarded a PhD in biochemistry from Strathclyde University, Glasgow, and the CEP diploma from the London Business School.

Agenda Sessions

  • Designing tomorrow’s biotech: The interdependent ecosystem of therapeutic areas, research collaborators, and innovative funding models

    11:30